October 5, 2015. Our Center strongly supports research and programs to improve drug safety. We remember when REMS were first proposed in legislation, the reason was to enable FDA to approve drugs with serious risks by providing a mechanism to mitigate those risks.
Read More »On Health Policy
NCHR at FDA Meeting on Essure Contraceptive
September 24, 2015. If the product is to be on the market, who should do the studies to accurately determine the short-term and long-term effectiveness and side effects? The company’s track record and response to the women’s reported complications is not acceptable. Any additional research should be conducted independently of the company so that patients can have confidence in its accuracy.
Read More »Comments to the U.S. Consumer Product Safety Commission Regarding Supplemental Mattresses
October 13, 2015. The National Center for Health Research supports Keeping Babies Safe’s (KBS) petition that requests a ban on supplemental mattresses for play yards with non-rigid sides. These mattresses present an unreasonable risk of injury or death (suffocation) to infants and toddlers.
Read More »Writing to Policy Makers
Elected officials at all levels are responsible for representing the interests of their constituents. Write to your elected officials to make sure they hear from you!
Read More »Calling Policy Makers
Elected officials at all levels are responsible for representing the interests of their constituents. Your elected officials must hear from you!
Read More »